Methods, devices, and systems induce neuromodulation by focusing a source of stimulation through a skull/brain interface in the form of an aperture formed in the skull, a naturally occurring fenestration in the skull, or a transcranial channel. Methods, devices, and systems identify where to locate skull/brain interfaces, accessories that can be used with the interfaces, and features for controlling stimulation delivered through the interfaces. Multiple indications for the skull/brain interfaces include diagnosis and treatment of neurological disorders and conditions such as epilepsy, movement disorders, depression, Alzheimer's disease, autism, coma, and pain.

There is disclosed systems and methods for non-invasive delivery of an agent to biological tissues. Delivery of the agent to the tissues can be by one or more modalities. In some embodiments the systems and methods use agent carrier body including a tissue contacting surface for non-invasively engaging tissues under treatment. The tissue contacting surface can be at least partly defined by a plurality of protrusions that are in fluid communication with one or more reservoirs forming part of the agent carrier body. The protrusions may extend outward from an inside of a void and terminate at said tissue contacting surface.

A thrombectomy catheter deployment for operation of a thrombectomy catheter may include a stand alone drive unit and a disposable pump/catheter assembly which is manually placed into a carriage assembly in the drive unit. The pump/catheter assembly may have a plurality of preconnected components including a tubular structure and a thrombectomy catheter connected thereto. A barcode reader may sense specific operational data pertaining to an individual pump and may provide an interface for operation of the reciprocating linear actuator.

Gold(I) complex with mixed ligands as an anticancer agent. The gold(I) ion is coordinated to a dithiocarbamate ligand and a phosphorus-containing ligand (e.g. phosphines). Also described are a pharmaceutical composition incorporating the gold(I) complex, a methods of synthesizing the gold(I) complex, and a method for treating cancer.

A content reproduction apparatus includes a storage unit storing a plurality of content files and performs treatments by playing the content files stored in the storage unit. The content reproduction apparatus also includes a treatment setting unit configured to set a treatment based on a treatment condition input by a user; a content file obtaining unit configured to obtain, from the storage unit, a content file corresponding to the treatment set by the treatment setting unit; and an edit-and-output unit configured to play the content file obtained by the content file obtaining unit or the content file edited according to an instruction of the user.

A content reproduction apparatus includes a storage unit storing a plurality of content files and performs treatments by playing the content files stored in the storage unit. The content reproduction apparatus also includes a treatment setting unit configured to set a treatment based on a treatment condition input by a user; a content file obtaining unit configured to obtain, from the storage unit, a content file corresponding to the treatment set by the treatment setting unit; and an edit-and-output unit configured to play the content file obtained by the content file obtaining unit or the content file edited according to an instruction of the user.

This disclosure provides self-applied wearable devices configured to electrically stimulate a user, generate and/or collect a user's electrophysiological data via electrodes, in contact with the outer layer of skin, that hydrate the skin surface using iontophoresis, reverse iontophoresis, and/or a combination thereof. The wearable devices provided herein increase conductivity and/or move biological ions and/or polar molecules from the electrode into the outer skin layer of skin surface to reduced impedance between the outer skin layer and electrode, wherein the impedance between electrodes is matched and/or minimized. This disclosure also provides systems comprising the same, and methods for making and using the same.

This disclosure provides self-applied wearable devices configured to electrically stimulate a user, generate and/or collect a user's electrophysiological data via electrodes, in contact with the outer layer of skin, that hydrate the skin surface using iontophoresis, reverse iontophoresis, and/or a combination thereof. The wearable devices provided herein increase conductivity and/or move biological ions and/or polar molecules from the electrode into the outer skin layer of skin surface to reduced impedance between the outer skin layer and electrode, wherein the impedance between electrodes is matched and/or minimized. This disclosure also provides systems comprising the same, and methods for making and using the same.

An electrode is provided that includes a wire that has a wire diameter of between 75 and 125 microns. The electrode includes a non-electrically-insulated current-application longitudinal segment, which, in the absence of any applied forces, is coiled and has (i) an outer coil diameter of between 3 and 7 times the wire diameter, and (ii) an entire longitudinal length of between 5 and 35 mm. The electrode further includes an electrically-insulated lead longitudinal segment, which has an entire longitudinal length of at least 10 mm, in the absence of any applied forces. Other embodiments are also described.

Methods and apparatus are provided for applying an fragment of a neurotoxin such as the active light chain (LC) of the botulinum toxin (BoNT), such as one of the serotype A, B, C, D, E, F or G botulinum toxins, via permeabilization of targeted cell membranes to enable translocation of the botulinum neurotoxin light chain (BoNT-LC) molecule across the targeted cell membrane to the cell cytosol where a therapeutic response is produced in a mammalian system. The methods and apparatus include use of catheter based delivery systems, non-invasive delivery systems, and transdermal delivery systems.